最新的帖子

九月 02, 2020

SARS-CoV-2 Vaccines – Alternative Vial Components

The need to provide vaccines for the SARS-CoV-2 pandemic has presented the pharmaceutical industry with unprecedented challenges. Among them are accelerated timelines for development/approval and unanticipated volumes for manufacture/delivery. Ordinarily for a new drug product, there is ample time for selecting the primary package system and establishing component availability.
Whitney Winters

Whitney Winters

Sr. Director, Strategic Marketing, Containment Systems

Categories

Search the Blog

Archive

  • 以前的博客
    By Your Side for Expertise

    三月 04, 2020

    By Your Side for Industry and Regulatory Trends

    Page McAndrew

    T. Page McAndrew, Ph.D.

    Director, Scientific Communications

    NanoPass Intradermal Injection

    七月 10, 2018

    5th International Conference on Microneedles

    Doug Hostetler

    Doug Hostetler

    Principle Technical SME, Admin. Systems, TCS

    十二月 15, 2014

    Managing Residual Moisture In Lyophilized Drugs

    West Author Logo

    Lynn Yao

    Senior Scientific Affairs Specialist

    一月 06, 2014

    Container Closure Integrity: What does it mean?

    West Author Logo

    Kristine Davidson

    Senior Category Specialist, Procurement

    CCI  labs  USP 
    Load more